Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanara MedTech Inc. Director's Dealing 2025

May 28, 2025

33339_dirs_2025-05-27_c3ab5629-60f5-4272-a712-fdd53e697986.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2025-05-22

Reporting Person: DeSutter Robert Andrew (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-22 Common Stock A 3746 Acquired 23201 Direct

Footnotes

F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date.